Search
VolitionRX Ltd
VNRXAdd to Watchlist
0.263USD
-0.002-0.75%
Close 09-22 16:00（ET）
3.05MMarket Cap
LossP/E TTM
Pre-market 05:17 (ET)0.262USD-0.001-0.38%
Pre-market 05:17 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.75%
5 Days
-9.00%
1 Month
-36.93%
6 Months
-92.97%
Year to Date
-94.86%
1 Year
-97.86%
Key Figures
0.263Open
0.264High
85.80KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.71%Turnover Ratio
0.265Prev. Close
0.255Low
22.17KTurnover
LossP/E Static
-0.10P/B
0.00%Div Yield TTM
-281.72%ROA
3.26052wk High
4.39Volume Ratio
-26.97MNet Profit
11.59MShares
-4.2173EPS TTM
1.06Beta
-5396.85%ROE
2.66052wk Low
3.02%Amplitude
100.00%Gross Margin
3.05MMarket Cap
-9.51Reward/Risk
123.23%Risk Rate
VolitionRX Ltd's Score
-0.06vs previous score
Forecast7.60
Financial Health5.70
Technical6.85
Valuation Dimensions9.31
Institutional Confidence3.00
Risk Assessment1.54
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
VolitionRX Ltd Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
VolitionRX Ltd Latest Earnings Call Transcripts
VolitionRx (VNRX) Q2 2026 Earnings Call: Costs Fall as Nu.Q Pipeline Advances
VolitionRx’s Q2 2026 revenue held at $0.4 million as expenses fell 32%. VNRX highlighted Nu.Q NETs, lung cancer reimbursement and feline milestones.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.80/-0.57
Revenue / Forecast
398.66K/482.67K
VolitionRX Ltd Profile
SectorBiotechnology & Medical Research
Ticker SymbolVNRX
Number of employees85
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Cotterford Co., Ltd. | 7.42% |
| Lagoda Investment Management, L.P. | 7.09% |
| The Lind Partners, LLC | 2.76% |
| Innes (Guy Archibald) | 2.43% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 11.58% |
| Corporation | 8.04% |
| Individual Investor | 7.07% |
| Investment Advisor/Hedge Fund | 1.07% |
Related Instruments
+0.45%
-0.10%
+0.28%
+0.94%
+0.21%
+0.16%
+4.34%
+1.40%
-1.01%
+0.68%
+0.84%
-0.59%
+0.54%
+0.02%
-0.70%
+0.72%
+5.56%
+0.32%
-2.47%
-1.64%
FAQs
What is the current price of VolitionRX Ltd (VNRX)?
The current price of VolitionRX Ltd (VNRX) is 0.26.
What is the symbol of VolitionRX Ltd?
The ticker symbol of VolitionRX Ltd is VNRX.
What is the 52-week high of VolitionRX Ltd?
The 52-week high of VolitionRX Ltd is 3.26.
What is the 52-week low of VolitionRX Ltd?
The 52-week low of VolitionRX Ltd is 0.26.
What is the market capitalization of VolitionRX Ltd?
The market capitalization of VolitionRX Ltd is 3.08M.
Is VolitionRX Ltd (VNRX) currently rated as Buy, Hold, or Sell?
According to analysts, VolitionRX Ltd (VNRX) has an overall rating of Buy, with a price target of 13.62.
What is the Earnings Per Share (EPS TTM) of VolitionRX Ltd (VNRX)?
The Earnings Per Share (EPS TTM) of VolitionRX Ltd (VNRX) is -4.22.